CBS and neoplasm: CBS expression in cutaneous melanoma tissues has been correlated with immune infiltration of CD8+ T cells, response to anti-PD-L1 immunotherapy, tumor microenvironment dynamics, MHC-I antigen presentation pathways, overall survival, tumor immune evasion, redox regulation, and immunotherapy efficacy.